HEMP EXTRACT FOR TREATMENT OF PAIN, CANCER AND EPILEPSY IN ANIMALS

1 . A pharmaceutical composition comprising hemp extract and a carrier, wherein the hemp extract comprises:

cannabidiol; and

cannabidiolic acid;

wherein the ratio of cannabidiol to cannabidiolic acid is about 0.6:1 to about 1:0.6, and

wherein the carrier comprises biopolymer NF-971P and/or lecithin.

2 . The pharmaceutical composition of claim 1 , wherein the hemp extract further comprises:

cannabigerolic acid;

Δ9-tetrahydrocannabinol; and

cannabichromene.

3 . The pharmaceutical composition of claim 1 , wherein the hemp extract further comprises four or more of:

α-pinene;

β-myrcene;

β-pinene;

δ-limonene;

linalool;

β-caryophyllene;

α-humulene;

nerolidol 2;

guaiol;

caryophyllene oxide; and

α-bisabolol.

4 . The pharmaceutical composition of claim 2 , wherein the concentration of Δ9-tetrahydrocannabinol is insufficient to produce a psychotropic effect.

5 .- 17 . (canceled)

18 . The pharmaceutical composition of claim 1 , wherein the carrier is selected from the group consisting of linseed oil, olive oil, fish oil, salmon oil, coconut oil, catnip oil, sesame oil, MCT oil, and grapeseed oil.

19 . (canceled)

20 . (canceled)

21 . The pharmaceutical composition of claim 1 , wherein the composition comprises lecithin.

22 .- 55 . (canceled)

56 . A dosage form comprising the pharmaceutical composition of claim 1 and one or more pharmaceutically acceptable additives, flavoring agents, surfactants, and adjuvants.

57 .- 68 . (canceled)

69 . The dosage form of claim 56 , wherein the composition is formulated as a chew for oral administration.

70 . The dosage form of claim 69 , where the chew is produced using cold extrusion.

71 . The dosage form of claim 70 , wherein the weight of the chew is about 0.5-10 g.

72 .- 129 . (canceled)

130 . A method of treating epilepsy in a veterinary subject in need thereof, comprising administering a therapeutically effective amount of a pharmaceutical composition comprising hemp extract and a carrier, wherein the hemp extract comprises:

cannabidiol; and

cannabidiolic acid;

wherein the ratio of cannabidiol to cannabidiolic acid is about 0.6:1 to about 1:0.6.

131 . A method of treating cancer in a veterinary subject in need thereof, comprising administering a therapeutically effective amount of a pharmaceutical composition comprising hemp extract and a carrier, wherein the hemp extract comprises:

cannabidiol; and

cannabidiolic acid;

wherein the ratio of cannabidiol to cannabidiolic acid is about 0.6:1 to about 1:0.6.

132 . A method of improving quality of life in a veterinary subject with cancer, comprising administering a therapeutically effective amount of a pharmaceutical composition comprising hemp extract and a carrier, wherein the hemp extract comprises:

cannabidiol; and

cannabidiolic acid;

wherein the ratio of cannabidiol to cannabidiolic acid is about 0.6:1 to about 1:0.6.

133 . The method of claim 130 , wherein the hemp extract further comprises:

cannabigerolic acid;

Δ9-tetrahydrocannabinol; and

cannabichromene.

134 . (canceled)

135 . The method of claim 133 , wherein the concentration of Δ9-tetrahydrocannabinol is insufficient to produce a psychotropic effect.

136 .- 149 . (canceled)

150 . The method of claim 130 , wherein the carrier is selected from the group consisting of linseed oil, olive oil, fish oil, salmon oil, coconut oil, catnip oil, sesame oil, MCT oil, and grapeseed oil.

151 .- 185 . (canceled)

186 . The method of claim 130 , comprising administering a dosage form comprising:

(a) the pharmaceutical composition, wherein the pharmaceutical composition further comprises:

(i) cannabigerolic acid,

(ii) Δ9-tetrahydrocannabinol,

(iii) cannabichromene; and

(b) one or more pharmaceutically acceptable additives, flavoring agents, surfactants, and adjuvants.

187 .- 221 . (canceled)

222 . The method of claim 186 , wherein the carrier is selected from the group consisting of linseed oil, olive oil, fish oil, salmon oil, coconut oil, catnip oil, sesame oil, MCT oil, and grapeseed oil.

223 .- 261 . (canceled)

262 . The method of claim 130 , wherein the composition comprises lecithin.

263 . The method of claim 222 , wherein the composition comprises lecithin.